Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen Replacement and Atherosclerosis Trial
NCT03097120Phase 3Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jan 1995
- Primary completion
- Jan 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of conjugated estrogens, medroxyprogesterone acetate in coronary artery disease (CAD), sponsored by Wake Forest University Health Sciences. Started Jan 1995; status: completed.
02
Drugs
conjugated estrogensmedroxyprogesterone acetate
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03097120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03097120.